Cargando…
Metformin regulates chondrocyte senescence and proliferation through microRNA-34a/SIRT1 pathway in osteoarthritis
BACKGROUND: Osteoarthritis (OA) is the most common degenerative disease in joints among elderly patients. Senescence is deeply involved in the pathogenesis of osteoarthritis. Metformin is widely used as the first-line drug for Type 2 diabetes mellitus (T2DM), and has great potential for the treatmen...
Autores principales: | Yan, Shiju, Dong, Wenjing, Li, Zhirui, Wei, Junqiang, Han, Tao, Wang, Junliang, Lin, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012483/ https://www.ncbi.nlm.nih.gov/pubmed/36915137 http://dx.doi.org/10.1186/s13018-023-03571-5 |
Ejemplares similares
-
MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis
por: YAN, SHIJU, et al.
Publicado: (2016) -
Sirt6 attenuates chondrocyte senescence and osteoarthritis progression
por: Ji, Ming-liang, et al.
Publicado: (2022) -
Kallistatin reduces vascular senescence and aging by regulating microRNA‐34a‐SIRT1 pathway
por: Guo, Youming, et al.
Publicado: (2017) -
Modulated Autophagy by MicroRNAs in Osteoarthritis Chondrocytes
por: Yu, Yinghao, et al.
Publicado: (2019) -
MicroRNA-34a and vascular senescence in diabetes
por: Thounaojam, Menaka C., et al.
Publicado: (2019)